Two Exceptional Brands Each Gifted with 0.5M Free Closures

A medical food for chemo/radiation patients and a low-sugar, carb, and calorie cold-pressed almond juice impress judges of Silgan Closures’ first Free Closures for a Year competition.

Origin Almond almond juice bottles
Packaging for Origin Almond’s almond juice includes an HPP-compatible 38-mm HDPE closure in the company’s signature yellow color.

In September, two companies offering unique products in their respective markets learned they were the winners of a contest held by Silgan Closures, with the award being up to a half-million free closures for their bottles. The winners were Entrinsic Health Solutions of Norwood, MA, with its enterade Advanced Oncology Formula, a medical food formulated to alleviate the gastrointestinal side effects of chemotherapy and radiation cancer treatment, and Magnolia, NJ-based Origin Almond, which produces a first-of-its-kind almond juice that has significantly less sugar, carbs, and calories than other traditional and cold-pressed fruit juices.

According to A.J. Miller, Director of Marketing for Silgan Closures, the Free Closures for a Year (FCFY) contest was initiated to promote Silgan’s stock closure program while giving fledgling brands a hand-up with their ventures. “The stock closure program caters to start-ups because it lets them purchase small/case quantities of closures,” he says. “We came up with FCFY because we recognized that start-ups tend to struggle with credit and the ability to purchase ingredients and packaging as well as pay for a co-packer before they start selling products. The contest is intended to make it a little easier for them.”

The entry requirements for the contest, which ran from Oct. 15, 2018 to April 30, 2019, were straightforward: “Food concepts must (a) be original; (b) must utilize or be able to utilize an existing Silgan closure.” The contest was open both to products in the concept stage as well as those already on the market.

To determine the winners, Silgan used information collected on each concept—there were six in total—through consumer surveys conducted by research partner Datassential. “We reviewed the consumer ratings with a focus on purchase intent and uniqueness,” explains Miller. “Then the panel of experts gave their input. Our panel included people from Datassential, Mintel, Kevin Metz Public Relations, and Silgan marketers. The winners were chosen based on their uniqueness, being on trend, and having the ability to use a Silgan Closures stock closure.”

The products from Entrinsic and Origin Almond were already commercial, but the award of free closures, as well as access to the Datassential results that came as part of the award, were deeply appreciated by the companies. Winning the FCFY contest has not only reduced their packaging costs, but it has also given their products greater visibility and has provided them with an opportunity to use consumer survey results to fine-tune their marketing strategies.

A ‘life-changing’ product

A medical food product that Entrinsic CMO Joe Del Regno says has been called "life-changing" by those consumers using it to combat the GI side effects of chemotherapy and radiation, enterade is the culmination of its founders’ dedication to finding a solution to the tragic numbers of deaths resulting from diarrhea and dysentery each year. “Something most people don’t realize is that every minute one child under the age of five dies from diarrhea around the world,” shares Del Regno.

Originating from India, Entrinsic Founder Dr. Sadasivan Vidyasagar saw firsthand the extent and seriousness of dehydration and as a result committed himself to researching and supporting healthy digestive function and hydration. Dr. Vidyasagar’s journey took him to Yale, where he worked with a leading GI expert. Their research led to a $40 million grant from NASA to work on the BioShield 4 Mission to Mars Project to study and address the adverse GI effects resulting from ionizing radiation during long-duration space travel.

enterade bottleThe 38-mm clear PP closure for enterade Advanced Oncology Formula was chosen for its ability to withstand retort temperatures and provide tamper-evidence.

“During their work, they made a profound discovery that has far-reaching implications,” shares Del Regno. “What they discovered was the ability to use combinations of functional elemental amino acids to treat disease. It was mission accomplished for deep space radiation countermeasures. But then Dr. Vidyasagar had an epiphany: If this formula could help repair GI damage from deep space radiation, could it help cancer patients whose GI tracks are decimated from cancer treatment, radiation, and chemotherapy? From there, enterade was born and with it, Entrinsic Health Solutions.”

Enterade uses a proprietary Amino Acid-Coupled Transport Technology (A2CT) and is recommended for those suffering from occasional diarrhea, cramping, dehydration, and nausea; patients undergoing treatment for cancer; and those diagnosed with conditions such as IBD (Crohn’s and colitis), IBS, celiac, and other GI issues. Entrinsic is also working on an amino acid-based formulations to address up to 2,500 other serious disease states.

Annual Outlook Report: Workforce
Hiring remains a major challenge in packaging, with 78% struggling to fill unskilled roles and 84% lacking experienced workers. As automation grows, companies must rethink hiring and training. Download the full report for key insights.
Download Now
Annual Outlook Report: Workforce
Annual Outlook Report: Automation & Robotics
What's in store for CPGs in 2025 and beyond? <i>Packaging World</i> editors explore the survey responses from 118 brand owners, CPG, and FMCG <i>Packaging World</i> readers for its new Annual Outlook Report.
Download
Annual Outlook Report: Automation & Robotics